Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

MR-Untersuchungen bei Patienten mit Herzschrittmachern und implantierbaren Kardioverter-Defibrillatoren : Konsensuspapier der Deutschen Gesellschaft fuer Kardiologie (DGK) und der Deutschen Roentgengesellschaft (DRG) [MR imaging in patients with cardiac pacemakers and implantable cardioverter Defibrillators : Consensus paper of the German Cardiac Society and the German Roentgen Society]

Item Type:Article
Title:MR-Untersuchungen bei Patienten mit Herzschrittmachern und implantierbaren Kardioverter-Defibrillatoren : Konsensuspapier der Deutschen Gesellschaft fuer Kardiologie (DGK) und der Deutschen Roentgengesellschaft (DRG) [MR imaging in patients with cardiac pacemakers and implantable cardioverter Defibrillators : Consensus paper of the German Cardiac Society and the German Roentgen Society]
Creators Name:Sommer, T. and Bauer, W. and Fischbach, K. and Kolb, C. and Luechinger, R. and Wiegand, U. and Lotz, J. and Eitel, I. and Gutberlet, M. and Thiele, H. and Schild, H.H. and Kelm, M. and Quick, H.H. and Schulz-Menger, J. and Barkhausen, J. and Bänsch, D.
Abstract:This joint consensus paper of the German Roentgen Society and the German Cardiac Society provides physical and electrophysiological background information and specific recommendations for the procedural management of patients with cardiac pacemakers (PM) and implantable cardioverter defibrillators (ICD) undergoing magnetic resonance (MR) imaging. The paper outlines the responsibilities of radiologists and cardiologists regarding patient education, indications, and monitoring with modification of MR sequences and PM/ICD reprogramming strategies being discussed in particular. The aim is to optimize patient safety and to improve legal clarity in order to facilitate the access of SM/ICD patients to MR imaging. Key Points: Conventional PM and ICD systems are no longer an absolute but rather a relative contraindication for performing an MR examination. Procedural management includes the assessment of the individual risk/benefit ratio, comprehensive patient informed consent about specific risks and "off label" use, extensive PM/ICD-related and MR-related safety precautions to reduce these risks to the greatest extent possible, as well as adequate monitoring techniques. MR conditional pacemaker and ICD systems have been tested and approved for MR examination under specific conditions ("in-label" use). Precise understanding of and compliance with the terms of use for the specific pacemaker system are essential for patient safety. The risk for an ICD patient during MR examinations is to be considered significantly higher compared to PM patients due to the higher vulnerability of the structurally damaged myocardium and the higher risk of irreversible damage to conventional ICD systems. The indication for a MR examination of an ICD patient should therefore be determined on a stricter basis and the expected risk/benefit ratio should be critically reviewed.This complex subject requires close collaboration between radiology and cardiology.
Keywords:MRI, Pacemaker, ICD, Guideline, MRI Safety
Source:RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
ISSN:1438-9029
Publisher:Georg Thieme Verlag KG (Germany)
Volume:189
Number:3
Page Range:204-217
Date:15 February 2017
Official Publication:https://doi.org/10.1055/s-0043-102029
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library